Targeting IL-11: A New Frontier in Anti-Ageing

Emerging research identifies interleukin-11 (IL-11), a cytokine linked to inflammation, as a significant contributor to age-related decline. Studies show that IL-11 levels rise with age, promoting fat accumulation and muscle loss, key indicators of frailty. Preclinical trials in mice demonstrated that inhibiting IL-11 improved metabolic and muscle function, reduced ageing biomarkers, and extended lifespan significantly.